These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25663903)

  • 61. Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis.
    Ni L; Wu J; Long Y; Tao J; Xu J; Yuan X; Yu N; Wu R; Zhang Y
    BMC Psychiatry; 2019 Oct; 19(1):323. PubMed ID: 31660909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetes mellitus and risk of bladder cancer: a meta-analysis.
    Larsson SC; Orsini N; Brismar K; Wolk A
    Diabetologia; 2006 Dec; 49(12):2819-23. PubMed ID: 17021919
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Natural history of surgically treated high-risk prostate cancer.
    Briganti A; Karnes RJ; Gandaglia G; Spahn M; Gontero P; Tosco L; Kneitz B; Chun FK; Zaffuto E; Sun M; Graefen M; Marchioro G; Frohneberg D; Giona S; Karakiewicz PI; Van Poppel H; Montorsi F; Joniau S;
    Urol Oncol; 2015 Apr; 33(4):163.e7-13. PubMed ID: 25665508
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
    Pinaquy JB; Allard JB; Cornelis F; Pasticier G; De Clermont H
    Clin Nucl Med; 2015 Apr; 40(4):e255-7. PubMed ID: 25674860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.
    Abdi H; Zargar H; Goldenberg SL; Walshe T; Pourmalek F; Eddy C; Chang SD; Gleave ME; Harris AC; So AI; Machan L; Black PC
    Urol Oncol; 2015 Apr; 33(4):165.e1-7. PubMed ID: 25665509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer.
    Falchook AD; Hendrix LH; Chen RC
    J Oncol Pract; 2015 Mar; 11(2):e239-46. PubMed ID: 25670199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.
    Wong LM; Neal DE; Finelli A; Davis S; Bonner C; Kapoor J; Trachtenberg J; Thomas B; Hovens CM; Costello AJ; Corcoran NM
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):137-43. PubMed ID: 25667108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
    Koo PJ; David Crawford E
    Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of metastatic hormone-sensitive prostate cancer.
    Bernard B; Sweeney CJ
    Curr Urol Rep; 2015 Mar; 16(3):14. PubMed ID: 25677237
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
    J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Four flawed arguments against prostate-specific antigen screening (and 1 good one).
    Vickers AJ
    Urology; 2015 Mar; 85(3):491-4. PubMed ID: 25733258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer.
    Afshar M; Al-Alloosh F; Pirrie S; Rowan C; James ND; Porfiri E
    Anticancer Res; 2015 Feb; 35(2):1057-63. PubMed ID: 25667494
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.
    Den RB; Yousefi K; Trabulsi EJ; Abdollah F; Choeurng V; Feng FY; Dicker AP; Lallas CD; Gomella LG; Davicioni E; Karnes RJ
    J Clin Oncol; 2015 Mar; 33(8):944-51. PubMed ID: 25667284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial.
    Petrylak DP; Vogelzang NJ; Budnik N; Wiechno PJ; Sternberg CN; Doner K; Bellmunt J; Burke JM; de Olza MO; Choudhury A; Gschwend JE; Kopyltsov E; Flechon A; Van As N; Houede N; Barton D; Fandi A; Jungnelius U; Li S; de Wit R; Fizazi K
    Lancet Oncol; 2015 Apr; 16(4):417-25. PubMed ID: 25743937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer.
    Qian SB; Shen HB; Cao QF; Zhang L; Chen YF; Qi J
    Int Urol Nephrol; 2015 Mar; 47(3):479-84. PubMed ID: 25665794
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy.
    Zhao B; Yerram NK; Gao T; Dreicer R; Klein EA
    Urol Oncol; 2015 Apr; 33(4):164.e19-23. PubMed ID: 25665510
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.
    Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF
    Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dietary fat and breast cancer mortality: A systematic review and meta-analysis.
    Brennan SF; Woodside JV; Lunny PM; Cardwell CR; Cantwell MM
    Crit Rev Food Sci Nutr; 2017 Jul; 57(10):1999-2008. PubMed ID: 25692500
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
    Joshua AM; Shore ND; Saad F; Chi KN; Olsson CA; Emmenegger U; Scholz M; Berry W; Mukherjee SD; Winquist E; Haas NB; Foley MA; Dmuchowski C; Perabo F; Hirmand M; Hasabou N; Rathkopf D;
    Prostate; 2015 Jun; 75(8):836-44. PubMed ID: 25683285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.